Breast cancer. Malignant neoplasm of breast (Breast, unspecified)
Conditions
Interventions
Intervention 1: Control :Every other day administration of GCSF up to three doses. Intervention 2: Intervention : Daily administration of GCSF up to three doses.
Treatment - Drugs
Treatment - Devices
Control :Every other day administration of GCSF up to three doses
Intervention : Daily administration of GCSF up to three doses
Sponsors
Ahvaz Jundishapur University of Medical Sceince
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: female patients more than 20 years old with breast cancer Exclusion criteria: Having no consent for taking apart in trial; History of Hypersensitivity to GCSF; Any active infection that may influence on cell blood counts; Patients more than 50 years old; Advanced renal or hepatic impairment or advanced cardiac disease that may have effect on cell blood count or patients ' symptoms and pain.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin. Timepoint: One week later. Method of measurement: Cell blood count test.;Platlet count. Timepoint: One week later. Method of measurement: Cell blood count test.;White blood cell count. Timepoint: One week later. Method of measurement: Cell blood count test.;Musculoskeletal pain. Timepoint: One week later. Method of measurement: McGill Pain Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTina Vosoghi
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed